Related Experiment Video
Updated: Aug 15, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3
Merja Matilainen1, Marjo Malinen, Katri Saavalainen
1Department of Biochemistry, University of Kuopio, P.O. box 1627, IN-70211 Kuopio, Finland.
Abstract:
Recently, insulin-like growth factor binding proteins (IGFBPs) have been found to be primary mediators of the anti-proliferative actions of the nuclear hormone 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3], but dependent on cellular context IGFBPs can also have a mitogenic effect. In this study, we performed expression profiling of all six human IGFBP genes in prostate and bone cancer cells and demonstrated that IGFBP1, 3 and 5 are primary 1alpha,25(OH)2D3 target genes. In silico screening of the 174 kb of genomic sequence surrounding all six IGFBP genes identified 15 candidate vitamin D response elements (VDREs) close to or in IGFBP1, 2, 3 and 5 but not in the IGFBP4 and 6 genes. The putative VDREs were evaluated in vitro by gelshift assays and in living cells by reporter gene and chromatin immuno-precipitation (ChIP) assays. Of these 10 VDREs appear to be functional. ChIP assays demonstrated for each of these an individual, stimulation time-dependent association profile not only with the vitamin D receptor, but also with first heterodimeric partner the retinoid X receptor, other regulatory complex components and phosphorylated RNA polymerase II. Some of the VDREs are located distantly from the transcription start sites of IGFBP1, 3 and 5, but all 10 VDREs seem to contribute to the regulation of the genes by 1alpha,25(OH)2D3. In conclusion, IGFBP1, 3 and 5 are primary 1alpha,25(OH)2D3 target genes that in intact cells are each under the control of multiple VDREs.
Insights
Insulin-like growth factor binding proteins (IGFBPs) 1, 3, and 5 are key targets of vitamin D (1alpha,25(OH)2D3) in cancer cells. Multiple vitamin D response elements (VDREs) control these IGFBP genes, influencing cell proliferation.
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- Insulin-like growth factor binding proteins (IGFBPs) mediate vitamin D's effects on cell proliferation.
- The role of IGFBPs in mediating 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3] actions is context-dependent, with potential anti-proliferative or mitogenic effects.
- Understanding IGFBP gene regulation by 1alpha,25(OH)2D3 is crucial for cancer therapy.
Purpose of the Study:
- To identify primary 1alpha,25(OH)2D3 target genes among the six human IGFBP genes in prostate and bone cancer cells.
- To locate and functionally characterize vitamin D response elements (VDREs) regulating IGFBP gene expression.
- To elucidate the mechanism of 1alpha,25(OH)2D3-mediated regulation of IGFBP genes.
Main Methods:
- Expression profiling of all six human IGFBP genes in prostate and bone cancer cells.
- In silico screening for VDREs in the genomic regions of IGFBP genes.
- In vitro gelshift assays, reporter gene assays, and chromatin immunoprecipitation (ChIP) assays to validate VDRE function and VDR binding.
Main Results:
- IGFBP1, IGFBP3, and IGFBP5 were identified as primary 1alpha,25(OH)2D3 target genes.
- Fifteen candidate VDREs were identified, with 10 found to be functional.
- ChIP assays confirmed the time-dependent association of VDREs with the vitamin D receptor (VDR), retinoid X receptor (RXR), and other transcriptional machinery components.
- Multiple VDREs, some located distantly, regulate IGFBP1, IGFBP3, and IGFBP5 expression.
Conclusions:
- IGFBP1, IGFBP3, and IGFBP5 are direct transcriptional targets of 1alpha,25(OH)2D3.
- Each of these genes is regulated by multiple functional VDREs in intact cells.
- This provides a deeper understanding of vitamin D's mechanism of action in cancer cells via IGFBP regulation.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Master Transcription Regulators
